Role of p53 in the anti-proliferative effects of Sirt1 inhibition in prostate cancer cells
Authors:
- 15 May 2009
- journal article
- Published by Taylor & Francis in Cell Cycle
- Vol. 8 (10) , 1478-1483
Abstract
Prostate Cancer (PCa), next only to skin cancer, is the most commonly occurring malignancy in men in the USA. Aging is recognized as a major risk factor for this neoplasm as a man’s chance for developing this disease significantly increases with increasing age. Because aging is inevitable, Americans are living longer, and the existing treatments have not been able to manage this neoplasm, novel mechanism-based approaches are needed. We have recently shown that Sirt1, a sirtuin class III histone deacetylases (HDACs) originally linked to aging and longevity in yeast, was overexpressed in human PCa cells and PCa tissues obtained from patients. We also found that chemical inhibition and/or genetic knockdown of Sirt1 caused a FoxO1-mediated inhibition in the growth and viability of human PCa cells. Since p53 is a target for deacetylation by Sirt1, we wanted to determine the involvement of p53 in Sirt1 inhibition mediated responses in PCa. To achieve our objective, we utilized a pair of isogenic PCa cell lines ...Keywords
This publication has 31 references indexed in Scilit:
- Role of Sirtuin Histone Deacetylase SIRT1 in Prostate CancerJournal of Biological Chemistry, 2009
- Control of Multidrug Resistance Gene mdr1 and Cancer Resistance to Chemotherapy by the Longevity Gene sirt1Cancer Research, 2005
- The Identification of Senescence-Specific Genes during the Induction of Senescence in Prostate Cancer CellsNeoplasia, 2005
- Ablation of either p21 or Bax prevents p53‐dependent apoptosis induced by green tea polyphenol epigallocatechin‐3‐gallateThe FASEB Journal, 2005
- Roles of SIRT1 and Phosphoinositide 3-OH Kinase/Protein Kinase C Pathways in Evodiamine-Induced Human Melanoma A375-S2 Cell DeathJournal of Pharmacological Sciences, 2005
- Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient miceProceedings of the National Academy of Sciences, 2003
- Alterations of p53 are common in early stage prostate cancer.2003
- Negative Control of p53 by Sir2α Promotes Cell Survival under StressCell, 2001
- SPECIFIC PROTEOLYTIC CLEAVAGE OF POLY(ADP-RIBOSE) POLYMERASE - AN EARLY MARKER OF CHEMOTHERAPY-INDUCED APOPTOSIS1993
- Identification of minimal size requirements of DNA for activation of poly(ADP-ribose) polymeraseBiochemistry, 1985